SERTAD1 and plasma cell myeloma: More importantly, the clinical data analysis of the patients in Figure 6T showed that compared to myeloma patients with low SEI1 expression, those with high SEI1 expression have faster disease progression, higher levels of lactate dehydrogenase in their serum, and a lower proportion of achieving complete remission after initial treatment (Table S2, Supporting Information).